Evidence map›Paper›PMID 32341527›Full record

SynthesisNature genetics2020

Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility.

Maria Teresa Landi, D Timothy Bishop, Stuart MacGregor, Mitchell J Machiela, Alexander J Stratigos, Paola Ghiorzo, Myriam Brossard, Donato Calista, Jiyeon Choi, Maria Concetta Fargnoli and 151 more

Abstract readMeta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Nature genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 140 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
140citing papers in PubMed, 11 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

140 citing papers in PubMed, 11 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Article
  13. Article
  14. Article
  15. Article
  16. Beyond the Classics: The Synergy of AI and Genomics Reveals an Expanded Repertoire of Pigmentation Genes.Journal of experimental zoology. Part B, Molecular and developmental evolution · 2026
    Review
  17. Unique Features of Melanoma Risk and Diagnosis in Red-Haired Populations.International journal of molecular sciences · 2026
    Review
  18. Article
  19. Interleukin-1β Gene (Current oncology (Toronto, Ont.) · 2026
    Article
  20. Article

80 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

161 authors.

Maria Teresa LandiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. landim@mail.nih.gov.ORCID http://orcid.org/0000-0003-4507-329X
D Timothy BishopLeeds Institute of Medical Research at St James's, Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.ORCID http://orcid.org/0000-0002-8752-8785
Stuart MacGregorStatistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0001-6731-8142
Mitchell J MachielaDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0001-6538-9705
Alexander J Stratigos *Department of Dermatology, Andreas Syggros Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Paola Ghiorzo *Genetics of Rare Cancers, Ospedale Policlinico San Martino, Genoa, Italy.
Myriam BrossardGenetic Epidemiology and Functional Genomics of Multifactorial Diseases Team, Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-1124, Université Paris Descartes, Paris, France.
Donato CalistaDepartment of Dermatology, Maurizio Bufalini Hospital, Cesena, Italy.
Jiyeon ChoiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Maria Concetta FargnoliDepartment of Dermatology & Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Tongwu ZhangDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0003-2124-2706
Monica RodolfoUnit of Immunotherapy of Human Tumors, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID http://orcid.org/0000-0002-9196-0298
Adam J TrowerLeeds Institute for Data Analytics, University of Leeds, Leeds, UK.
Chiara MeninImmunology and Molecular Oncology Unit, Venito Institute of Oncology IOV-IRCCS, Padua, Italy.
Jacobo MartinezRed Valenciana de Biobancos, FISABIO, Valencia, Spain.
Andreas HadjisavvasDepartment of EM/Molecular Pathology & The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Lei SongDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Irene StefanakiDepartment of Dermatology, University of Athens School of Medicine, Andreas Sygros Hospital, Athens, Greece.
Richard ScolyerMelanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.ORCID http://orcid.org/0000-0002-8991-0013
Rose YangDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Alisa M GoldsteinDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-7538-3582
Miriam PotronyDermatology Department, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, CIBERER, Barcelona, Spain.ORCID http://orcid.org/0000-0003-2766-0765
Katerina P KypreouDepartment of Dermatology, University of Athens School of Medicine, Andreas Sygros Hospital, Athens, Greece.
Lorenza PastorinoGenetics of Rare Cancers, Ospedale Policlinico San Martino, Genoa, Italy.
Paola QueiroloMedical Oncology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Cristina PellegriniDepartment of Dermatology & Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Laura CattaneoPathology Unit, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
Matthew ZawistowskiDepartment of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0002-3005-083X
Pol Gimenez-XavierDermatology Department, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, CIBERER, Barcelona, Spain.
Arantxa RodriguezDepartment of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain.
Lisa ElefantiImmunology and Molecular Oncology Unit, Venito Institute of Oncology IOV-IRCCS, Padua, Italy.
Siranoush ManoukianUnit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Licia RivoltiniUnit of Immunotherapy of Human Tumors, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Blair H SmithDivision of Population Health and Genomics, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.ORCID http://orcid.org/0000-0002-5362-9430
Maria A LoizidouDepartment of EM/Molecular Pathology & The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Laura Del RegnoInstitute of Dermatology, Catholic University, Rome, Italy.ORCID http://orcid.org/0000-0002-3692-629X
Daniela MassiSection of Anatomic Pathology, Department of Health Sciences, University of Florence, Florence, Italy.
Mario MandalaDepartment of Oncology, Giovanni XXIII Hospital, Bergamo, Italy.
Kiarash KhosrotehraniUQ Diamantina Institute, The University of Queensland, Brisbane, Queensland, Australia.
Lars A AkslenCentre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Christopher I AmosDepartment of Community and Family Medicine, Geisel School of Medicine, Dartmouth College, Hanover, NH, USA.ORCID http://orcid.org/0000-0002-8540-7023
Per A AndresenDepartment of Pathology, Molecular Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Marie-Françoise AvrilAssistance Publique-Hôpitaux de Paris, Hôpital Cochin, Service de Dermatologie, Université Paris Descartes, Paris, France.
Esther AziziDepartment of Dermatology, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv, Israel.
H Peter SoyerDepartment of Dermatology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0002-4770-561X
Veronique BatailleDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.
Bruna DalmassoGenetics of Rare Cancers, Ospedale Policlinico San Martino, Genoa, Italy.
Lisa M BowdlerSample Processing, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Kathryn P BurdonMenzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.ORCID http://orcid.org/0000-0001-8217-1249
Wei V ChenDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Veryan CoddDepartment of Cardiovascular Sciences, University of Leicester, Leicester, UK.
Jamie E CraigDepartment of Ophthalmology, Flinders University, Adelaide, South Australia, Australia.
Tadeusz DębniakDepartment of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
Mario FalchiDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.
Shenying FangDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Eitan FriedmanOncogenetics Unit, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Sarah SimiSection of Anatomic Pathology, Department of Health Sciences, University of Florence, Florence, Italy.
Pilar GalanUniversité Paris 13, Equipe de Recherche en Epidémiologie Nutritionnelle (EREN), Centre de Recherche en Epidémiologie et Statistiques, Institut National de la Santé et de la Recherche Médicale (INSERM U1153), Institut National de la Recherche Agronomique (INRA U1125), Conservatoire National des Arts et Métiers, Communauté d'Université Sorbonne Paris Cité, Bobigny, France.ORCID http://orcid.org/0000-0003-1706-3107
Zaida Garcia-CasadoDepartment of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain.
Elizabeth M GillandersInherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Baltimore, MD, USA.
Scott GordonGenetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0001-7623-328X
Adele GreenCancer and Population Studies, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Nelleke A GruisDepartment of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands.
Johan HanssonDepartment of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Mark HarlandLeeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Jessica HarrisTranslational Research Institute, Institute of Health and Biomedical Innovation, Princess Alexandra Hospital, Queensland University of Technology, Brisbane, Queensland, Australia.
Per HelsingDepartment of Dermatology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Anjali HendersInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
Marko HočevarDepartment of Surgical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Veronica HöiomDepartment of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
David HunterNuffield Department of Population Health, University of Oxford, Oxford, UK.
Christian IngvarDepartment of Surgery, Clinical Sciences, Lund University, Lund, Sweden.
Rajiv KumarDivision of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-6093-0395
Julie LangDepartment of Medical Genetics, University of Glasgow, Glasgow, UK.
G Mark LathropMcGill University and Genome Quebec Innovation Centre, Montreal, Canada.
Jeffrey E LeeDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Xin LiDepartment of Epidemiology, Richard M. Fairbanks School of Public Health, Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, IN, USA.
Jan LubińskiInternational Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
Rona M MackieDepartment of Medical Genetics, University of Glasgow, Glasgow, UK.
Maryrose MaltCancer and Population Studies, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Josep MalvehyDermatology Department, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, CIBERER, Barcelona, Spain.
Kerrie McAloneyGenetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Hamida MohamdiGenetic Epidemiology and Functional Genomics of Multifactorial Diseases Team, Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-1124, Université Paris Descartes, Paris, France.
Anders MolvenDepartment of Pathology, Haukeland University Hospital, Bergen, Norway.
Eric K MosesCentre for Genetic Origins of Health and Disease, Faculty of Medicine, Dentistry and Health Sciences, The University of Western Australia, Crawley, Western Australia, Australia.
Rachel E NealeCancer Aetiology & Prevention, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Srdjan NovakovićDepartment of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Dale R NyholtGenetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0001-7159-3040
Håkan OlssonDepartment of Oncology/Pathology, Clinical Sciences, Lund University, Lund, Sweden.
Nicholas OrrBreakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.ORCID http://orcid.org/0000-0003-2866-942X
Lars G FritscheCenter for Statistical Genetics, Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0002-2110-1690
Joan Anton Puig-ButilleBiochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona,CIBERER, Barcelona, Spain.
Abrar A QureshiDepartment of Dermatology, The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Graham L Radford-SmithInflammatory Bowel Diseases, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0002-2047-6239
Juliette Randerson-MoorLeeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.ORCID http://orcid.org/0000-0003-0303-0072
Celia RequenaDepartment of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain.
Casey RoweUQ Diamantina Institute, The University of Queensland, Brisbane, Queensland, Australia.
Nilesh J SamaniDepartment of Cardiovascular Sciences, University of Leicester, Leicester, UK.
Marianna SannaDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.
Dirk SchadendorfDepartment of Dermatology, University Hospital Essen, Essen, Germany.ORCID http://orcid.org/0000-0003-3524-7858
Hans-Joachim SchulzeDepartment of Dermatology, Fachklinik Hornheide, Institute for Tumors of the Skin, University of Münster, Münster, Germany.
Lisa A SimmsInflammatory Bowel Diseases, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Mark SmithersQueensland Melanoma Project, Princess Alexandra Hospital, The University of Queensland, St Lucia, Queensland, Australia.ORCID http://orcid.org/0000-0002-8333-8685
Fengju SongDepartments of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, Tianjin, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P. R. China.
Anthony J SwerdlowDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Nienke van der StoepDepartment of Clinical Genetics, Center of Human and Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
Nicole A KukutschDepartment of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands.
Alessia ViscontiDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.ORCID http://orcid.org/0000-0003-4144-2019
Leanne WallaceInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
Sarah V WardCentre for Genetic Origins of Health and Disease, School of Biomedical Sciences, The University of Western Australia, Perth, Western Australia, Australia.
Lawrie WheelerTranslational Research Institute, Institute of Health and Biomedical Innovation, Princess Alexandra Hospital, Queensland University of Technology, Brisbane, Queensland, Australia.
Richard A SturmDermatology Research Centre, The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0003-1301-0294
Amy HutchinsonDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Kristine JonesDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Michael MalaskyDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Aurelie VogtDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Weiyin ZhouDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Karen A PooleyDepartment of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
David E ElderDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Jiali HanDepartment of Epidemiology, Richard M. Fairbanks School of Public Health, Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, IN, USA.
Belynda HicksDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0001-8014-4888
Nicholas K HaywardOncogenomics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Peter A KanetskyDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.ORCID http://orcid.org/0000-0002-5567-9618
Chad BrummettDepartment of Anesthesiology, University of Michigan, Ann Arbor, MI, USA.
Grant W MontgomeryInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0002-4140-8139
Catherine M OlsenCancer Control Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0003-4483-1888
Caroline HaywardMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK.ORCID http://orcid.org/0000-0002-9405-9550
Alison M DunningDepartment of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0001-6651-7166
Nicholas G MartinGenetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0003-4069-8020
Evangelos EvangelouDepartment of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece.
Graham J MannMelanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.ORCID http://orcid.org/0000-0003-1301-405X
Georgina LongMelanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Paul D P PharoahDepartment of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0001-8494-732X
Douglas F EastonDepartment of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0003-2444-3247
Jennifer H BarrettLeeds Institute for Data Analytics, University of Leeds, Leeds, UK.ORCID http://orcid.org/0000-0002-1720-7724
Anne E CustMelanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Goncalo AbecasisDepartment of Biostatistics, University of Michigan, Ann Arbor, MI, USA.
David L DuffyDermatology Research Centre, The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Queensland, Australia.
David C WhitemanCancer Control Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0003-2563-9559
Helen GogasFirst Department of Internal Medicine, Laikon General Hospital Greece, National and Kapodistrian University of Athens, Athens, Greece.
Arcangela De NicoloCancer Genomics Program, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
Margaret A TuckerDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Julia A Newton-BishopLeeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
GenoMEL Consortium
Q-MEGA and QTWIN Investigators
ATHENS Melanoma Study Group
23andMe
SDH Study Group
IBD Investigators
Essen-Heidelberg Investigators
AMFS Investigators
MelaNostrum Consortium
Ketty PerisInstitute of Dermatology, Catholic University, Rome, Italy.
Stephen J ChanockDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-2324-3393
Florence DemenaisGenetic Epidemiology and Functional Genomics of Multifactorial Diseases Team, Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS-1124, Université Paris Descartes, Paris, France.ORCID http://orcid.org/0000-0001-8361-0936
Kevin M Brown *Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Susana Puig *Dermatology Department, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, CIBERER, Barcelona, Spain.
Eduardo Nagore *Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain.ORCID http://orcid.org/0000-0003-3433-8707
Jianxin ShiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Mark M IlesLeeds Institute for Data Analytics, University of Leeds, Leeds, UK. M.M.Iles@leeds.ac.uk.ORCID http://orcid.org/0000-0002-2603-6509
Matthew H LawStatistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. Matthew.Law@qimrberghofer.edu.au.ORCID http://orcid.org/0000-0002-4303-8821

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Statistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI TWOROGER, SHELLEY S · 2000 to 2019
$77.8M
Validity of Diet and Activity Measures in WomenP01CA055075 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI WILLETT, WALTER C. · 1991 to 2009
$41.8M
Genetic Epidermiology of MelanomaR01CA083115 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BISHOP, DAVID TIMOTHY, ELDER, DAVID ERIC · 2001 to 2017
$13.0M
BIOCHEMICAL MARKERS IN THE NURSES'HEALTH STUDY COHORTR01CA049449 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI HANKINSON, SUSAN E · 1989 to 2008
$11.3M
Ovarian cancer GWAS discovery, expansion and replication (N2 - Project #1)U19CA148112 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI SELLERS, THOMAS A · 2010 to 2014
$10.2M
BIOCHEMICAL MARKERS IN THE NURSES HEALTH STUDY COHORTU01CA049449 · NCI · UNIVERSITY OF MASSACHUSETTS AMHERST · PI HANKINSON, SUSAN E · 1995 to 2013
$5.4M
Pathways from genotype and environment to melanomaR01CA088363 · NCI · QUEENSLAND INSTITUTE OF MEDICAL RESEARCH · PI HAYWARD, NICHOLAS K · 2001 to 2012
$2.4M
GEI - Genome-Wide Association StudiesZIACP010200 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI CAPORASO, NEIL E. · 2009 to 2021
$2.3M
Genetic Predictors for DNA Repair Phenotype in CMMR01CA100264 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WEI, QINGYI · 2004 to 2008
$1.5M
Cohort Study of Genetic Susceptibility to Cutaneous Malignant MelanomaR01CA122838 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI HAN, JIALI · 2008 to 2010
$1.4M
Statistical Methods for Gene Environment Interactions In Lung CancerR01CA133996 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AMOS, CHRISTOPHER I. · 2007 to 2009
$790k
Cancer Research UK 10118Cancer Research UK 10589Cancer Research UK 19167Cancer Research UK 29186Cancer Research UK C490/A16561Intramural NIH HHS ZIA CP010200Medical Research Council MC_UU_00007/10NCI NIH HHS P01 CA055075NCI NIH HHS P01 CA087969NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA049449NCI NIH HHS R01 CA083115NCI NIH HHS R01 CA088363NCI NIH HHS R01 CA100264NCI NIH HHS R01 CA122838NCI NIH HHS R01 CA133996NCI NIH HHS U01 CA049449NCI NIH HHS U19 CA148112Wellcome TrustWellcome Trust WT084766/Z/08/Z
6 · The paper itself

Abstract

Most genetic susceptibility to cutaneous melanoma remains to be discovered. Meta-analysis genome-wide association study (GWAS) of 36,760 cases of melanoma (67% newly genotyped) and 375,188 controls identified 54 significant (P < 5 × 10

Indexed as

Cutaneous Malignant MelanomaFemaleGenetic LociGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHumansMaleMelanomaPhenotypePigmentationPolymorphism, Single NucleotideSkin Neoplasms

Identifiers

PMID32341527
PMCPMC7255059

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.